American Society of Hematology, Blood, 17(125), p. 2669-2677
DOI: 10.1182/blood-2014-06-584193
Full text: Download
Key Points miR-18b overexpression identified patients with poor prognosis in 2 large prospective homogenously treated MCL cohorts. miR-18b overexpression adds prognostic information to the MIPI-B prognosticator.